Clear Street Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)

March 24, 2026 3:02 PM

Clear Street analyst Kaveri Pohlman reiterated a Buy rating and $777.00 price target on Cullinan Oncology Inc. (NASDAQ: CGEM).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found